Sciarra A - Search Results

1

Monti S, Proietti-Pannunzi L, Sciarra A, Lolli F, Falasca P, Poggi M, Celi FS, Toscano V. Monti S, et al. Among authors: sciarra a. Curr Pharm Des. 2007;13(7):719-27. doi: 10.2174/138161207780249128. Curr Pharm Des. 2007. PMID: 17346186 Review.

2

Effects of long-term treatment with Serenoa repens (Permixon) on the concentrations and regional distribution of androgens and epidermal growth factor in benign prostatic hyperplasia.

Di Silverio F, Monti S, Sciarra A, Varasano PA, Martini C, Lanzara S, D'Eramo G, Di Nicola S, Toscano V. Di Silverio F, et al. Among authors: sciarra a. Prostate. 1998 Oct 1;37(2):77-83. doi: 10.1002/(sici)1097-0045(19981001)37:2<77::aid-pros3>3.0.co;2-i. Prostate. 1998. PMID: 9759701

3

Can the intraprostatic concentration of epidermal growth factor influence the variance of serum prostate specific antigen levels in patients with benign prostatic hyperplasia?

Di Silverio F, Sciarra A, Monti S, Casale P, Seccareccia F. Di Silverio F, et al. Among authors: sciarra a. J Urol. 1999 Jan;161(1):128-32. doi: 10.1097/00005392-199901000-00041. J Urol. 1999. PMID: 10037384

4

Neuroendocrine differentiation in human prostate tissue: is it detectable and treatable?

Sciarra A, Mariotti G, Gentile V, Voria G, Pastore A, Monti S, Di Silverio F. Sciarra A, et al. BJU Int. 2003 Mar;91(5):438-45. doi: 10.1046/j.1464-410x.2003.03066.x. BJU Int. 2003. PMID: 12603395 Review. No abstract available.

5

Variation of chromogranin A serum levels after radical retropubic prostatectomy for prostate adenocarcinoma.

Sciarra A, Gentile V, Monti S, Mariotti G, Pastore A, Di Silverio F. Sciarra A, et al. Arch Androl. 2003 Jan-Feb;49(1):39-48. doi: 10.1080/01485010390129160. Arch Androl. 2003. PMID: 12647777 Clinical Trial.

6

Variation in chromogranin A serum levels during intermittent versus continuous androgen deprivation therapy for prostate adenocarcinoma.

Sciarra A, Monti S, Gentile V, Mariotti G, Cardi A, Voria G, Lucera R, Di Silverio F. Sciarra A, et al. Prostate. 2003 May 15;55(3):168-79. doi: 10.1002/pros.10222. Prostate. 2003. PMID: 12692782 Clinical Trial.

7

Clinical understaging in patients with prostate adenocarcinoma submitted to radical prostatectomy: predictive value of serum chromogranin A.

Sciarra A, Voria G, Monti S, Mazzone L, Mariotti G, Pozza M, D'Eramo G, Silverio FD. Sciarra A, et al. Prostate. 2004 Mar 1;58(4):421-8. doi: 10.1002/pros.10347. Prostate. 2004. PMID: 14968443

8

Combination therapy with rofecoxib and finasteride in the treatment of men with lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH).

Di Silverio F, Bosman C, Salvatori M, Albanesi L, Proietti Pannunzi L, Ciccariello M, Cardi A, Salvatori G, Sciarra A. Di Silverio F, et al. Among authors: sciarra a. Eur Urol. 2005 Jan;47(1):72-8; discussion 78-9. doi: 10.1016/j.eururo.2004.08.024. Eur Urol. 2005. PMID: 15582252 Clinical Trial.

9

Chromogranin A expression in familial versus sporadic prostate cancer.

Sciarra A, Monti S, Gentile V, Salciccia S, Autran Gòmez AM, Pannunzi LP, Di Silverio F. Sciarra A, et al. Urology. 2005 Nov;66(5):1010-4. doi: 10.1016/j.urology.2005.05.045. Urology. 2005. PMID: 16286114

10

Prostate growth and inflammation.

Sciarra A, Mariotti G, Salciccia S, Autran Gomez A, Monti S, Toscano V, Di Silverio F. Sciarra A, et al. J Steroid Biochem Mol Biol. 2008 Feb;108(3-5):254-60. doi: 10.1016/j.jsbmb.2007.09.013. Epub 2007 Sep 7. J Steroid Biochem Mol Biol. 2008. PMID: 17935971 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

382 results

Search Page

Filters